Get Real Time Here
| Open9.090 | Close- |
| Vol / Avg.1.346M / 3.639M | Mkt Cap2.254B |
| Day Range8.895 - 9.110 | 52 Wk Range4.975 - 14.550 |
Pacific Biosciences Stock (NASDAQ:PACB), Quotes and News Summary
Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
| Open9.090 | Close- |
| Vol / Avg.1.346M / 3.639M | Mkt Cap2.254B |
| Day Range8.895 - 9.110 | 52 Wk Range4.975 - 14.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.320 | -0.260 | 0.0600 | ||||
| REV | 40.300M | 47.573M | 7.273M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Ross Osborn | Reiterates | NeutralNeutral | Maintains | - | 14.00 |
| 2023-08-04 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 13.00 | 13.00 |
| 2023-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-WeightEqual-Weight | Raises | 12.00 | 13.00 |
| 2023-06-30 | Goldman Sachs | - | Initiates Coverage On | Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PACB | Pacific Biosciences | -0.06% | 2.3B |
| MEDP | Medpace Hldgs | 1.21% | 7.4B |
| A | Agilent Technologies | 1.48% | 32.6B |
| TXG | 10x Genomics | -0.39% | 4.9B |
| SYNH | Syneos Health | -0.02% | 4.4B |
How do I buy Pacific Biosciences (PACB) stock?
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Who are Pacific Biosciences's (PACB) competitors?
Other companies in Pacific Biosciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Pacific Biosciences (PACB) stock?
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 14.00 expecting PACB to rise to within 12 months (a possible 55.64% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Pacific Biosciences (PACB)?
The stock price for Pacific Biosciences (NASDAQ: PACB) is $8.995 last updated Today at September 22, 2023 at 5:10 PM UTC.
Does Pacific Biosciences (PACB) pay a dividend?
There is no dividend information for Pacific Biosciences.
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences’s Q3 earnings are confirmed for Monday, November 6, 2023.
Is Pacific Biosciences (PACB) going to split?
There is no upcoming split for Pacific Biosciences.
What sector and industry does Pacific Biosciences (PACB) operate in?
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Pacific Biosciences Stock (NASDAQ:PACB), Quotes and News Summary
Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
| Open9.090 | Close- |
| Vol / Avg.1.346M / 3.639M | Mkt Cap2.254B |
| Day Range8.895 - 9.110 | 52 Wk Range4.975 - 14.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.320 | -0.260 | 0.0600 | ||||
| REV | 40.300M | 47.573M | 7.273M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Ross Osborn | Reiterates | NeutralNeutral | Maintains | - | 14.00 |
| 2023-08-04 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 13.00 | 13.00 |
| 2023-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-WeightEqual-Weight | Raises | 12.00 | 13.00 |
| 2023-06-30 | Goldman Sachs | - | Initiates Coverage On | Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PACB | Pacific Biosciences | -0.06% | 2.3B |
| MEDP | Medpace Hldgs | 1.21% | 7.4B |
| A | Agilent Technologies | 1.48% | 32.6B |
| TXG | 10x Genomics | -0.39% | 4.9B |
| SYNH | Syneos Health | -0.02% | 4.4B |
How do I buy Pacific Biosciences (PACB) stock?
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Who are Pacific Biosciences's (PACB) competitors?
Other companies in Pacific Biosciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Pacific Biosciences (PACB) stock?
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 14.00 expecting PACB to rise to within 12 months (a possible 55.64% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Pacific Biosciences (PACB)?
The stock price for Pacific Biosciences (NASDAQ: PACB) is $8.995 last updated Today at September 22, 2023 at 5:10 PM UTC.
Does Pacific Biosciences (PACB) pay a dividend?
There is no dividend information for Pacific Biosciences.
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences’s Q3 earnings are confirmed for Monday, November 6, 2023.
Is Pacific Biosciences (PACB) going to split?
There is no upcoming split for Pacific Biosciences.
What sector and industry does Pacific Biosciences (PACB) operate in?
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Pacific Biosciences Stock (NASDAQ:PACB), Quotes and News Summary
Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
| Open9.090 | Close- |
| Vol / Avg.1.346M / 3.639M | Mkt Cap2.254B |
| Day Range8.895 - 9.110 | 52 Wk Range4.975 - 14.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.320 | -0.260 | 0.0600 | ||||
| REV | 40.300M | 47.573M | 7.273M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Ross Osborn | Reiterates | NeutralNeutral | Maintains | - | 14.00 |
| 2023-08-04 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 13.00 | 13.00 |
| 2023-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-WeightEqual-Weight | Raises | 12.00 | 13.00 |
| 2023-06-30 | Goldman Sachs | - | Initiates Coverage On | Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PACB | Pacific Biosciences | -0.06% | 2.3B |
| MEDP | Medpace Hldgs | 1.21% | 7.4B |
| A | Agilent Technologies | 1.48% | 32.6B |
| TXG | 10x Genomics | -0.39% | 4.9B |
| SYNH | Syneos Health | -0.02% | 4.4B |
How do I buy Pacific Biosciences (PACB) stock?
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Who are Pacific Biosciences's (PACB) competitors?
Other companies in Pacific Biosciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Pacific Biosciences (PACB) stock?
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 14.00 expecting PACB to rise to within 12 months (a possible 55.64% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Pacific Biosciences (PACB)?
The stock price for Pacific Biosciences (NASDAQ: PACB) is $8.995 last updated Today at September 22, 2023 at 5:10 PM UTC.
Does Pacific Biosciences (PACB) pay a dividend?
There is no dividend information for Pacific Biosciences.
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences’s Q3 earnings are confirmed for Monday, November 6, 2023.
Is Pacific Biosciences (PACB) going to split?
There is no upcoming split for Pacific Biosciences.
What sector and industry does Pacific Biosciences (PACB) operate in?
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Pacific Biosciences Stock (NASDAQ:PACB), Quotes and News Summary
Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
| Open9.090 | Close- |
| Vol / Avg.1.346M / 3.639M | Mkt Cap2.254B |
| Day Range8.895 - 9.110 | 52 Wk Range4.975 - 14.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.320 | -0.260 | 0.0600 | ||||
| REV | 40.300M | 47.573M | 7.273M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Ross Osborn | Reiterates | NeutralNeutral | Maintains | - | 14.00 |
| 2023-08-04 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 13.00 | 13.00 |
| 2023-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-WeightEqual-Weight | Raises | 12.00 | 13.00 |
| 2023-06-30 | Goldman Sachs | - | Initiates Coverage On | Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PACB | Pacific Biosciences | -0.06% | 2.3B |
| MEDP | Medpace Hldgs | 1.21% | 7.4B |
| A | Agilent Technologies | 1.48% | 32.6B |
| TXG | 10x Genomics | -0.39% | 4.9B |
| SYNH | Syneos Health | -0.02% | 4.4B |
How do I buy Pacific Biosciences (PACB) stock?
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Who are Pacific Biosciences's (PACB) competitors?
Other companies in Pacific Biosciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Pacific Biosciences (PACB) stock?
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 14.00 expecting PACB to rise to within 12 months (a possible 55.64% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Pacific Biosciences (PACB)?
The stock price for Pacific Biosciences (NASDAQ: PACB) is $8.995 last updated Today at September 22, 2023 at 5:10 PM UTC.
Does Pacific Biosciences (PACB) pay a dividend?
There is no dividend information for Pacific Biosciences.
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences’s Q3 earnings are confirmed for Monday, November 6, 2023.
Is Pacific Biosciences (PACB) going to split?
There is no upcoming split for Pacific Biosciences.
What sector and industry does Pacific Biosciences (PACB) operate in?
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Pacific Biosciences Stock (NASDAQ:PACB), Quotes and News Summary
Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
| Open9.090 | Close- |
| Vol / Avg.1.346M / 3.639M | Mkt Cap2.254B |
| Day Range8.895 - 9.110 | 52 Wk Range4.975 - 14.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.320 | -0.260 | 0.0600 | ||||
| REV | 40.300M | 47.573M | 7.273M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Ross Osborn | Reiterates | NeutralNeutral | Maintains | - | 14.00 |
| 2023-08-04 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 13.00 | 13.00 |
| 2023-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-WeightEqual-Weight | Raises | 12.00 | 13.00 |
| 2023-06-30 | Goldman Sachs | - | Initiates Coverage On | Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PACB | Pacific Biosciences | -0.06% | 2.3B |
| MEDP | Medpace Hldgs | 1.21% | 7.4B |
| A | Agilent Technologies | 1.48% | 32.6B |
| TXG | 10x Genomics | -0.39% | 4.9B |
| SYNH | Syneos Health | -0.02% | 4.4B |
How do I buy Pacific Biosciences (PACB) stock?
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Who are Pacific Biosciences's (PACB) competitors?
Other companies in Pacific Biosciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Pacific Biosciences (PACB) stock?
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 14.00 expecting PACB to rise to within 12 months (a possible 55.64% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Pacific Biosciences (PACB)?
The stock price for Pacific Biosciences (NASDAQ: PACB) is $8.995 last updated Today at September 22, 2023 at 5:10 PM UTC.
Does Pacific Biosciences (PACB) pay a dividend?
There is no dividend information for Pacific Biosciences.
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences’s Q3 earnings are confirmed for Monday, November 6, 2023.
Is Pacific Biosciences (PACB) going to split?
There is no upcoming split for Pacific Biosciences.
What sector and industry does Pacific Biosciences (PACB) operate in?
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Pacific Biosciences Stock (NASDAQ:PACB), Quotes and News Summary
Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
| Open9.090 | Close- |
| Vol / Avg.1.346M / 3.639M | Mkt Cap2.254B |
| Day Range8.895 - 9.110 | 52 Wk Range4.975 - 14.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.320 | -0.260 | 0.0600 | ||||
| REV | 40.300M | 47.573M | 7.273M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Ross Osborn | Reiterates | NeutralNeutral | Maintains | - | 14.00 |
| 2023-08-04 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 13.00 | 13.00 |
| 2023-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-WeightEqual-Weight | Raises | 12.00 | 13.00 |
| 2023-06-30 | Goldman Sachs | - | Initiates Coverage On | Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PACB | Pacific Biosciences | -0.06% | 2.3B |
| MEDP | Medpace Hldgs | 1.21% | 7.4B |
| A | Agilent Technologies | 1.48% | 32.6B |
| TXG | 10x Genomics | -0.39% | 4.9B |
| SYNH | Syneos Health | -0.02% | 4.4B |
How do I buy Pacific Biosciences (PACB) stock?
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Who are Pacific Biosciences's (PACB) competitors?
Other companies in Pacific Biosciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Pacific Biosciences (PACB) stock?
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 14.00 expecting PACB to rise to within 12 months (a possible 55.64% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Pacific Biosciences (PACB)?
The stock price for Pacific Biosciences (NASDAQ: PACB) is $8.995 last updated Today at September 22, 2023 at 5:10 PM UTC.
Does Pacific Biosciences (PACB) pay a dividend?
There is no dividend information for Pacific Biosciences.
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences’s Q3 earnings are confirmed for Monday, November 6, 2023.
Is Pacific Biosciences (PACB) going to split?
There is no upcoming split for Pacific Biosciences.
What sector and industry does Pacific Biosciences (PACB) operate in?
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Pacific Biosciences Stock (NASDAQ:PACB), Quotes and News Summary
Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
| Open9.090 | Close- |
| Vol / Avg.1.346M / 3.639M | Mkt Cap2.254B |
| Day Range8.895 - 9.110 | 52 Wk Range4.975 - 14.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.320 | -0.260 | 0.0600 | ||||
| REV | 40.300M | 47.573M | 7.273M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Ross Osborn | Reiterates | NeutralNeutral | Maintains | - | 14.00 |
| 2023-08-04 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 13.00 | 13.00 |
| 2023-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-WeightEqual-Weight | Raises | 12.00 | 13.00 |
| 2023-06-30 | Goldman Sachs | - | Initiates Coverage On | Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PACB | Pacific Biosciences | -0.06% | 2.3B |
| MEDP | Medpace Hldgs | 1.21% | 7.4B |
| A | Agilent Technologies | 1.48% | 32.6B |
| TXG | 10x Genomics | -0.39% | 4.9B |
| SYNH | Syneos Health | -0.02% | 4.4B |
How do I buy Pacific Biosciences (PACB) stock?
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Who are Pacific Biosciences's (PACB) competitors?
Other companies in Pacific Biosciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Pacific Biosciences (PACB) stock?
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 14.00 expecting PACB to rise to within 12 months (a possible 55.64% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Pacific Biosciences (PACB)?
The stock price for Pacific Biosciences (NASDAQ: PACB) is $8.995 last updated Today at September 22, 2023 at 5:10 PM UTC.
Does Pacific Biosciences (PACB) pay a dividend?
There is no dividend information for Pacific Biosciences.
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences’s Q3 earnings are confirmed for Monday, November 6, 2023.
Is Pacific Biosciences (PACB) going to split?
There is no upcoming split for Pacific Biosciences.
What sector and industry does Pacific Biosciences (PACB) operate in?
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Pacific Biosciences Stock (NASDAQ:PACB), Quotes and News Summary
Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
| Open9.090 | Close- |
| Vol / Avg.1.346M / 3.639M | Mkt Cap2.254B |
| Day Range8.895 - 9.110 | 52 Wk Range4.975 - 14.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.320 | -0.260 | 0.0600 | ||||
| REV | 40.300M | 47.573M | 7.273M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Ross Osborn | Reiterates | NeutralNeutral | Maintains | - | 14.00 |
| 2023-08-04 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 13.00 | 13.00 |
| 2023-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-WeightEqual-Weight | Raises | 12.00 | 13.00 |
| 2023-06-30 | Goldman Sachs | - | Initiates Coverage On | Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PACB | Pacific Biosciences | -0.06% | 2.3B |
| MEDP | Medpace Hldgs | 1.21% | 7.4B |
| A | Agilent Technologies | 1.48% | 32.6B |
| TXG | 10x Genomics | -0.39% | 4.9B |
| SYNH | Syneos Health | -0.02% | 4.4B |
How do I buy Pacific Biosciences (PACB) stock?
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Who are Pacific Biosciences's (PACB) competitors?
Other companies in Pacific Biosciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Pacific Biosciences (PACB) stock?
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 14.00 expecting PACB to rise to within 12 months (a possible 55.64% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Pacific Biosciences (PACB)?
The stock price for Pacific Biosciences (NASDAQ: PACB) is $8.995 last updated Today at September 22, 2023 at 5:10 PM UTC.
Does Pacific Biosciences (PACB) pay a dividend?
There is no dividend information for Pacific Biosciences.
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences’s Q3 earnings are confirmed for Monday, November 6, 2023.
Is Pacific Biosciences (PACB) going to split?
There is no upcoming split for Pacific Biosciences.
What sector and industry does Pacific Biosciences (PACB) operate in?
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Pacific Biosciences Stock (NASDAQ:PACB), Quotes and News Summary
Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
| Open9.090 | Close- |
| Vol / Avg.1.346M / 3.639M | Mkt Cap2.254B |
| Day Range8.895 - 9.110 | 52 Wk Range4.975 - 14.550 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.320 | -0.260 | 0.0600 | ||||
| REV | 40.300M | 47.573M | 7.273M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Ross Osborn | Reiterates | NeutralNeutral | Maintains | - | 14.00 |
| 2023-08-04 | Morgan Stanley | Tejas Savant | Reiterates | Equal-WeightEqual-Weight | Maintains | 13.00 | 13.00 |
| 2023-08-03 | Morgan Stanley | Tejas Savant | Maintains | Equal-WeightEqual-Weight | Raises | 12.00 | 13.00 |
| 2023-06-30 | Goldman Sachs | - | Initiates Coverage On | Buy | Announces | - | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| PACB | Pacific Biosciences | -0.06% | 2.3B |
| MEDP | Medpace Hldgs | 1.21% | 7.4B |
| A | Agilent Technologies | 1.48% | 32.6B |
| TXG | 10x Genomics | -0.39% | 4.9B |
| SYNH | Syneos Health | -0.02% | 4.4B |
How do I buy Pacific Biosciences (PACB) stock?
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Who are Pacific Biosciences's (PACB) competitors?
Other companies in Pacific Biosciences’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), Syneos Health (NASDAQ:SYNH) and Waters (NYSE:WAT).
What is the target price for Pacific Biosciences (PACB) stock?
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 14.00 expecting PACB to rise to within 12 months (a possible 55.64% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Pacific Biosciences (PACB)?
The stock price for Pacific Biosciences (NASDAQ: PACB) is $8.995 last updated Today at September 22, 2023 at 5:10 PM UTC.
Does Pacific Biosciences (PACB) pay a dividend?
There is no dividend information for Pacific Biosciences.
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences’s Q3 earnings are confirmed for Monday, November 6, 2023.
Is Pacific Biosciences (PACB) going to split?
There is no upcoming split for Pacific Biosciences.
What sector and industry does Pacific Biosciences (PACB) operate in?
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.